FAM3A (Family with sequence similarity 3. member A) is a cytokine-like protein encoded by the FAM3A gene, part of the FAM3 family (FAM3A, B, C, D) characterized by four conserved α-helical domains. It is widely expressed in tissues, including the pancreas, liver, and brain, and plays roles in metabolic regulation, cellular stress response, and mitochondrial function. Studies suggest FAM3A regulates glucose and lipid metabolism by modulating mitochondrial activity, ATP production, and insulin signaling pathways. It has been implicated in diabetes, obesity, neurodegenerative diseases, and cancer, though its mechanisms remain partially unclear. For instance, FAM3A may suppress hepatic gluconeogenesis, enhance β-cell survival, and protect neurons from oxidative stress. However, conflicting reports exist about its role in cancer, showing both tumor-suppressive and pro-metastatic effects depending on context.
FAM3A antibodies are essential tools for detecting and quantifying FAM3A protein levels in research. They enable investigations into its expression patterns, interactions, and functional roles via techniques like Western blot, immunohistochemistry, and immunofluorescence. Commercial antibodies are typically developed against specific epitopes, such as the N-terminal or C-terminal regions, and validated for specificity in human, mouse, or rat samples. Reliable FAM3A antibodies are critical for elucidating its dual roles in metabolic homeostasis and disease progression, aiding therapeutic targeting studies. However, variability in antibody performance (e.g., cross-reactivity, batch consistency) requires careful validation to ensure experimental accuracy.